Yemen

in page functions
[French]
Yemen
Total population (2017) 28,119,471
Birth cohort (2017) 866,557
Surviving Infants (surviving to 1 year per year, 2017) 824,145
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 34/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 42/1000
World Bank Index, IDA (2015) 2.61
Gross Nation Income (per capita US$, 2015) 1,140
Co-financing group (2017) Preparatory transition
No. of districts/territories (2015) 333

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Yemen

Type of support

Approvals

2001-2021 (US$)
(29 Jun 2017)

Commitments

2001-2021 (US$)
(29 Jun 2017)

Disbursements

2000-2017 (US$)
(29 Jun 2017)

% Disbursed

(29 Jun 2017)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Total $230,086,993 $235,619,415 $226,210,688
Health system strengthening (HSS 1) $6,335,000 $6,335,000 $6,335,000 100%
Health system strengthening (HSS 2) $14,279,312 $17,639,234 $12,948,232 91%
Immunisation services support (ISS) $5,049,500 $5,049,500 $5,049,500 100%
Injection Safety Devices (NVS) $313,000 $313,000 $396,937 127%
Injection safety support (INS) $1,194,757 $1,194,757 $1,194,757 100%
IPV (NVS) $3,786,991 $5,959,491 $2,502,722 66%
Measles-Rubella (NVS) $8,313,136 $8,313,136 $8,313,136 100%
MR - Operational costs (OPC) $7,533,500 $7,533,500 $7,533,500 100%
Penta (NVS) $72,252,487 $72,252,487 $73,356,038 102%
Pneumo (NVS) $89,260,528 $89,260,528 $87,956,283 99%
Rotavirus (NVS) $19,659,782 $19,659,782 $18,515,583 94%
Vaccine Introduction Grant (VIG) $2,109,000 $2,109,000 $2,109,000 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Yemen DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 86%
M:F sex ratio at birth (2017) 1.05
Household survey: DTP3 coverage for male (2012) 59.70%
Household survey: DTP3 coverage for female (2012) 59.60%
Household survey: Last DTP3 survey (2012) 60%
% districts achieving > 80% DTP3 coverage (2015) 64%
% districts achieving < 50% DTP3 coverage (2015) 10%
MCV WHO/UNICEF estimates (2016) 70%

Breakdown of support

Non-vaccine support Vaccine support
16% 84%
$35,169,989 $191,040,699

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Yemen

15 June 2017

DRC: a nurse vaccinates a child

Gavi to help protect millions more children against polio

Gavi Board agrees to extend support for inactivated polio vaccine (IPV) to 2020; new policy on fragile settings, emergencies and refugees also approved.

05 October 2016

Saudi Development Fund signing

Gavi welcomes contribution of US$ 25 million from the Kingdom of Saudi Arabia

Investment will help Vaccine Alliance partners save children’s lives through immunisation in Yemen.

close icon

modal window here